These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27736965)

  • 1. Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect.
    Pan Z; He J; Rasoul LM; Liu Y; Che R; Ding Y; Guo X; Yang J; Zou D; Zhang H; Li D; Cao H
    PLoS One; 2016; 11(10):e0164723. PubMed ID: 27736965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model.
    Niu Z; Bai F; Sun T; Tian H; Yu D; Yin J; Li S; Li T; Cao H; Yu Q; Wu Y; Ren G; Li D
    Technol Cancer Res Treat; 2015 Oct; 14(5):607-15. PubMed ID: 24645750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.
    Bai FL; Yu YH; Tian H; Ren GP; Wang H; Zhou B; Han XH; Yu QZ; Li DS
    Cancer Biol Ther; 2014 Sep; 15(9):1226-38. PubMed ID: 24971746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice.
    Wei D; Li Q; Wang XL; Wang Y; Xu J; Feng F; Nan G; Wang B; Li C; Guo T; Chen ZN; Bian H
    J Exp Clin Cancer Res; 2015 Dec; 34():153. PubMed ID: 26689432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.
    An Y; Liu T; He J; Wu H; Chen R; Liu Y; Wu Y; Bai Y; Guo X; Zheng Q; Liu C; Yin J; Li D; Ren G
    J Biomed Sci; 2016 Jul; 23(1):55. PubMed ID: 27465066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy.
    Tian L; Liu T; Jiang S; Cao Y; Kang K; Su H; Ren G; Wang Z; Xiao W; Li D
    Gene Ther; 2023 Feb; 30(1-2):64-74. PubMed ID: 34602608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rescue of a recombinant Newcastle disease virus expressing the green fluorescent protein].
    Ge JY; Wen ZY; Wang Y; Bao ED; Bu ZG
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):547-51. PubMed ID: 17037052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression.
    Zhao W; Zhang Z; Zsak L; Yu Q
    J Gen Virol; 2015 Jan; 96(Pt 1):40-45. PubMed ID: 25274858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.
    Ren G; Tian G; Liu Y; He J; Gao X; Yu Y; Liu X; Zhang X; Sun T; Liu S; Yin J; Li D
    Technol Cancer Res Treat; 2016 Oct; 15(5):NP83-94. PubMed ID: 26303327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.
    He J; Pan Z; Tian G; Liu X; Liu Y; Guo X; An Y; Song L; Wu H; Cao H; Yu D; Che R; Xu P; Rasoul LM; Li D; Yin J
    Virus Res; 2016 Aug; 221():23-9. PubMed ID: 27164362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy.
    Bai F; Niu Z; Tian H; Li S; Lv Z; Zhang T; Ren G; Li D
    Immunol Lett; 2014; 159(1-2):36-46. PubMed ID: 24613899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antitumor response to fibrosarcoma by Newcastle disease virus-infected tumor vaccine.
    Takamura-Ishii M; Miura T; Nakaya T; Hagiwara K
    Med Oncol; 2017 Sep; 34(10):171. PubMed ID: 28864944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
    Vijayakumar G; McCroskery S; Palese P
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.
    Buijs P; van Nieuwkoop S; Vaes V; Fouchier R; van Eijck C; van den Hoogen B
    Viruses; 2015 Jun; 7(6):2980-98. PubMed ID: 26110582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy.
    Zhao H; Janke M; Fournier P; Schirrmacher V
    Virus Res; 2008 Sep; 136(1-2):75-80. PubMed ID: 18538434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus.
    Bian H; Fournier P; Moormann R; Peeters B; Schirrmacher V
    Cancer Gene Ther; 2005 Mar; 12(3):295-303. PubMed ID: 15605075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor efficacy of the recombinant Newcastle disease virus rNDV-IL15 on melanoma models].
    Niu ZS; Bai FL; Sun T; Tian H; Yin JC; Cao HW; Yu D; Tian GY; Wu YZ; Li DS; Ren GP
    Yao Xue Xue Bao; 2014 Mar; 49(3):310-5. PubMed ID: 24961100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.
    Wu Y; Yan S; Lv Z; Chen L; Geng J; He J; Yu Q; Yin J; Ren G; Li D
    Technol Cancer Res Treat; 2014 Apr; 13(2):169-75. PubMed ID: 23819497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.
    Chai Z; Zhang P; Fu F; Zhang X; Liu Y; Hu L; Li X
    Virol J; 2014 May; 11():84. PubMed ID: 24885546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.